scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJM199601043340104 |
P698 | PubMed publication ID | 7494565 |
P2093 | author name string | Jones PG | |
Schwartz SM | |||
Brummitt CF | |||
Vakil NB | |||
Buggy BP | |||
Gilson IH | |||
Kherellah M | |||
Letzer DM | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cryptosporidiosis | Q1359898 |
P304 | page(s) | 19-23 | |
P577 | publication date | 1996-01-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee | |
P478 | volume | 334 |
Q30361870 | A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis |
Q50164465 | AIDS Cholangiopathy |
Q38368265 | AIDS Cholangiopathy in an Asymptomatic, Previously Undiagnosed Late-Stage HIV-Positive Patient from Kenya |
Q41093918 | Acalculous Cholecystitis Due to Histoplasma capsulatum in a Patient With HIV Infection |
Q41418382 | Agents of diarrhea |
Q56985996 | Analysis of the genetic diversity withinCryptosporidium hominisandCryptosporidium parvumfrom imported and autochtonous cases of human cryptosporidiosis by mutation scanning |
Q34001000 | Characterization of an immunogenic glycocalyx on the surfaces of Cryptosporidium parvum oocysts and sporozoites |
Q34210651 | Cholangiopathy in HIV-infected patients |
Q35734582 | Cholestasis in HIV-infected patients |
Q90709567 | Co-infection risk assessment of Giardia and Cryptosporidium with HIV considering synergistic effects and age sensitivity using disability-adjusted life years |
Q73671653 | Cryptosporidiosis and inflammatory bowel disease. Experience from the Milwaukee outbreak |
Q30439621 | Cryptosporidiosis: an emerging, highly infectious threat |
Q30308822 | Cryptosporidiosis: an update |
Q37762488 | Cryptosporidiosis: environmental, therapeutic, and preventive challenges |
Q30309853 | Cryptosporidiosis: epidemiology and impact |
Q35559983 | Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines |
Q41005798 | Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism |
Q40012825 | Detection of Cryptosporidium parvum DNA in formed human feces by a sensitive PCR-based assay including uracil-N-glycosylase inactivation |
Q40011121 | Detection of Cryptosporidium parvum DNA in human feces by nested PCR. |
Q44571230 | Effects of pine bark extract administered to immunosuppressed adult mice infected with Cryptosporidium parvum |
Q24797760 | Endemic cryptosporidiosis and exposure to municipal tap water in persons with acquired immunodeficiency syndrome (AIDS): a case-control study |
Q33906166 | Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients |
Q38622793 | Evaluation of indeterminate biliary strictures |
Q39455463 | Gallbladder and biliary tract disease in AIDS. |
Q33650105 | Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer |
Q34212799 | Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the |
Q36397124 | Human intestinal and biliary cryptosporidiosis. |
Q34003719 | Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection |
Q40903803 | Mechanisms of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells |
Q33749117 | New insights into human cryptosporidiosis |
Q77355681 | New perspectives on the pathogenesis of Cryptosporidium biliary disease |
Q77527258 | Pollutants in our water: effects on human health and the environment |
Q54778971 | Polymerase chain reaction-based diagnosis of infection with Cryptosporidium in children with primary immunodeficiencies |
Q36729308 | Prevalence of intestinal infection due to Cryptosporidium species among Taiwanese patients with human immunodeficiency virus infection |
Q83668409 | Risks of recreational exposure to waterborne pathogens among persons with HIV/AIDS in Baltimore, Maryland |
Q33763109 | Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection |
Q41527229 | The therapy of gastrointestinal infections associated with the acquired immunodeficiency syndrome |
Q54148024 | Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. |
Q82735018 | [Intraabdominal infection in inmunodepressed patients] |
Search more.